コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 mesoderm), JUN and FOS families, and MEIS2 (cardiomyocyte).
2 teractions with the microvasculature and the cardiomyocyte.
3 two levels of resting membrane potential in cardiomyocytes.
4 cardiomyoblasts, neuronal cells, and primary cardiomyocytes.
5 tk expression in platelets, T lymphocytes or cardiomyocytes.
6 an heart's low inherent capacity to form new cardiomyocytes.
7 art, isolated tissue preparations and single cardiomyocytes.
8 view has been that metoprolol acts mainly on cardiomyocytes.
9 -knockout mice and Herpud1 siRNA-treated rat cardiomyocytes.
10 free mitochondrial calcium concentration in cardiomyocytes.
11 s, but not genomic RNAs, in human and murine cardiomyocytes.
12 BIN1-microfolds are externally released from cardiomyocytes.
13 phenotype results from the loss of GAS2L3 in cardiomyocytes.
14 gulator FoxO in the nuclei of ncx1-deficient cardiomyocytes.
15 notably muscle creation through division of cardiomyocytes.
16 connected in vitro neonatal rat ventricular cardiomyocytes.
17 /-) mice because of changes in subepicardial cardiomyocytes.
18 ain the normal resting membrane potential of cardiomyocytes.
19 formation and fusion activity in ventricular cardiomyocytes.
20 induce cytokine response in macrophages and cardiomyocytes.
21 urther establish that TNFalpha induces IR in cardiomyocytes.
22 on protein quality control and autophagy in cardiomyocytes.
23 tion into fibroblast-like cells but not into cardiomyocytes.
24 that govern the contractile function of the cardiomyocytes.
25 y maintain the resting membrane potential of cardiomyocytes.
26 ction impairment and myofibril disruption in cardiomyocytes.
27 e potential and depolarize in synchrony with cardiomyocytes.
28 evels of resting membrane potential of human cardiomyocytes.
29 oning by a mechanism stemming primarily from cardiomyocytes.
30 osyltransferase and stimulates glycolysis in cardiomyocytes.
31 eceptors, which was blunted in Nod1(-/-)-PMI cardiomyocytes.
32 S. pneumoniae rapidly adhered to and invaded cardiomyocytes.
33 soderm, cardiac mesoderm, and differentiated cardiomyocytes.
34 mammalian heart undergoes limited renewal of cardiomyocytes.
35 dult and human pluripotent stem cell-derived cardiomyocytes; (2) 2-dimensional in vitro models, such
36 sters of human pluripotent stem cell-derived cardiomyocytes; (3) 3-dimensional multicellular in vitro
37 cent endoderm control the medial movement of cardiomyocytes, a process referred to as cardiac fusion.
38 GAS2L3 results in premature binucleation of cardiomyocytes accompanied by unresolved midbody structu
40 IONALE: There are several methods to measure cardiomyocyte and muscle contraction, but these require
42 o mesodermal, cardiac progenitors and mature cardiomyocytes and an enhanced ability to differentiate
43 nflammasome and caspase-I hyperactivation in cardiomyocytes and cardiac macrophages in peri-infarct r
44 cell-derived factor 1, that is expressed in cardiomyocytes and decreases calcium influx across the L
46 ic and induced pluripotent stem cell-derived cardiomyocytes and fibroblasts with organotypic function
47 or populations that enable the derivation of cardiomyocytes and functionally distinct endothelial cel
50 ncer patients, elevate glucose and sensitize cardiomyocytes and mice to the cancer drug doxorubicin (
54 sing directions across the S(E)R membrane in cardiomyocytes and that changes in their activity play a
55 es PDK4 (pyruvate dehydrogenase kinase 4) in cardiomyocytes and that elevated PDK4 levels in late pre
56 MitoCam) was expressed in cultured adult rat cardiomyocytes and the free mitochondrial calcium concen
57 mically controls PABPC1 protein synthesis in cardiomyocytes and thereby titrates cellular translation
59 ffects by activating its nuclear receptor in cardiomyocytes and vascular endothelial cells and by reg
60 Ca(2+)-dependent transcriptional pathways in cardiomyocytes, and (3) discuss implications of excitati
61 ited inflammasome activation in macrophages, cardiomyocytes, and cardiac fibroblasts via proteinase-a
62 zithromycin in vivo and in vitro using mice, cardiomyocytes, and human ion channels heterologously ex
63 occurs via the proliferation of pre-existing cardiomyocytes, and is regulated by aerobic-respiration-
64 ttenuated cardiomyocyte hypertrophy, reduced cardiomyocyte apoptosis, fibrosis, calcium/calmodulin-de
65 erations in cardiac morphology, and elevated cardiomyocyte apoptosis, which were mitigated in the cat
67 rdial ischaemia-reperfusion-injury (IRI) and cardiomyocytes are a known source of complement proteins
68 human induced pluripotent stem cell-derived cardiomyocytes are a powerful model for screening varian
71 an pluripotent stem-cell-derived ventricular cardiomyocytes are strategically aligned to reproduce ke
73 lso shown a change in DNA methylation within cardiomyocytes as a result of in utero exposure to diese
74 neage tracing to mark the Nppa(+) or Hey2(+) cardiomyocytes as trabecular and compact components of t
75 atrium and ventricle appeared to be working cardiomyocytes based on their morphological appearance a
78 imarily because of proliferation of existing cardiomyocytes but not from the differentiation of putat
80 crease of expression and activity of iNOS in cardiomyocytes by VCP is an essential mechanistic link o
82 ecting cardiomyocyte membrane potentials and cardiomyocyte-cardiomyocyte gap junctional coupling, TGF
84 dicating that the majority of injury-induced cardiomyocyte cell cycle activity results in binucleatio
85 ions between pathways that are important for cardiomyocyte cell cycle reentry, with relevance to vent
86 nd regeneration, the mechanisms that promote cardiomyocyte cell cycle remain incompletely understood.
87 o mechanisms by which NUMB and NUMBL promote cardiomyocyte cell cycle withdrawal and highlight previo
88 en our particular datasets on cultured human cardiomyocyte cell lines, we find that, while convention
89 onally, in human embryonic stem cell-derived cardiomyocytes challenged with TNFalpha or FFA, we demon
90 alian vertebrates such as zebrafish activate cardiomyocyte (CM) division after tissue damage to regen
92 ncentrations reduced insulin sensitivity and cardiomyocyte contractility, which was rescued by CD36 s
93 p junctional coupling, TGF-beta1 depolarized cardiomyocytes coupled to myofibroblasts by approximatel
94 asts and by cessation of ectopic activity of cardiomyocytes coupled to myofibroblasts during pharmaco
99 tile dysfunction, cardiomyocyte hypertrophy, cardiomyocyte death, and N-terminal pro B-type natriuret
102 mRNA sequences analyzed from a population of cardiomyocytes derived from human induced pluripotent st
103 In the present study, we show that human cardiomyocytes derived from induced pluripotent stem cel
104 Under hypokalaemic conditions, both human cardiomyocytes derived from induced pluripotent stem cel
106 odulatory role in fine-tuning human-specific cardiomyocyte development by forming a regulatory networ
107 Heart Brake LncRNA 1 (HBL1), which regulates cardiomyocyte development from human induced pluripotent
108 differentiation of HLHS-iPSC restored their cardiomyocyte differentiation capacity and beating rate
109 n accessibility at genome-wide levels during cardiomyocyte differentiation derived from 2 hiPSC lines
113 is revealed that transcriptomes during early cardiomyocyte differentiation were highly concordant bet
114 y important roles at different stages during cardiomyocyte differentiation, such as T and eomesodermi
117 erived induced pluripotent stem cell-derived cardiomyocytes display (1) significantly prolonged actio
119 7) (which accumulates in doxorubicin-treated cardiomyocytes) displays decreased C-terminal tail primi
121 ing the transcriptional program of postnatal cardiomyocytes during heart development has been shown,
122 We conclude that NS-cardiomyopathy involves cardiomyocytes, ECs and fibroblasts, TNF/IL6 signalling
123 s demonstrated by immediate normalization of cardiomyocyte electrophysiology after targeted disruptio
124 y co-culturing human primary or iPSC-derived cardiomyocytes, endothelial cells and fibroblasts at rat
125 h as exosomes secreted from the iPSC-derived cardiomyocytes exert protective effects by transferring
128 or pharmacological inhibition of v-ATPase in cardiomyocytes exposed to low palmitate concentrations r
129 re with preserved ejection fraction (HFpEF), cardiomyocyte-extracellular matrix interactions from exc
132 induced pluripotent stem cell (iPSC)-derived cardiomyocytes from a patient with a gain-of-function mu
133 vances have improved our ability to generate cardiomyocytes from human induced pluripotent stem cells
135 le cellular differentiation, specifically in cardiomyocytes from physiologically and pathologically h
138 nctional coupling between myofibroblasts and cardiomyocytes >5-fold as reflected by elevated connexin
140 f MEF2 isoform-specific function in neonatal cardiomyocytes has yielded insight into an unexpected tr
142 METHODS AND Extending our previous hMSC-cardiomyocyte HC computational model, we incorporated ex
143 Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) are increasingly being used fo
144 Human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) offer a novel in vitro platfo
145 human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) provide new possibilities for
146 human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), but D-ala,RP produgs, includ
147 human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), Tbx20 enhanced human KCNH2 g
150 onstrate that H-Ras, but not K-Ras, promotes cardiomyocyte hypertrophy both in vivo and in vitro.
151 bition of cardiomyocyte proliferation and to cardiomyocyte hypertrophy during embryonic development.
154 cts of cardiac remodeling, such as fibrosis, cardiomyocyte hypertrophy, and calcium handling (Col1a2,
155 amine toxicity with contractile dysfunction, cardiomyocyte hypertrophy, cardiomyocyte death, and N-te
156 llowing TAC, cyclin D2 expression attenuated cardiomyocyte hypertrophy, reduced cardiomyocyte apoptos
159 n isoform shift, and contractile behavior of cardiomyocytes in heart tissue of PPCM and DCM patients
160 e behaviour in single membrane-permeabilized cardiomyocytes in human left ventricular heart tissue.
161 as a nearly 2-fold increase in the number of cardiomyocytes in mitosis indicating that the majority o
162 n of the human pluripotent stem cell-derived cardiomyocytes in our system recapitulates in vivo devel
163 orchestrates critical epigenetic changes in cardiomyocytes in physiological and pathological conditi
164 L5 on the electrophysiological properties of cardiomyocytes in relation to the lectin-like oxidized L
166 ntribution of c-Kit(+) cardiac stem cells to cardiomyocytes in the heart and the contribution of Sox9
168 examine the physiologic role of p53 in adult cardiomyocytes in vivo, Cre-loxP-mediated conditional ge
170 iac gene expression and differentiation into cardiomyocytes; in contrast, restricting Hdac3 to the nu
174 d that 1) paracrine signaling from stretched cardiomyocytes induces CFB proliferation under mechanica
175 ial direct reprogramming of mesoderm-derived cardiomyocytes into neurons is feasible, generating cell
181 by structural remodelling of the specialised cardiomyocytes known collectively as the cardiac conduct
182 experimentally calibrated hMSC PS effects on cardiomyocyte L-type calcium channel/sarcoendoplasmic re
183 usly generated directly reprogrammed induced cardiomyocyte-like cells (iCMs) by overexpression of Gat
184 gramming of cardiac fibroblasts into induced cardiomyocyte-like cells in situ represents a promising
185 ion of human dermal fibroblasts into induced cardiomyocyte-like cells via transcription factor overex
186 (GMT), can convert fibroblasts into induced cardiomyocyte-like cells, albeit with low efficiency in
190 heart is incapable of regeneration following cardiomyocyte loss, which underpins the lasting and seve
191 We were able to predict the proportion of cardiomyocytes many days before cells manifest the diffe
199 dimensional in vitro models, such as beating cardiomyocyte monolayers or small clusters of human plur
203 t (Ito) in EPI but not in endocardial (ENDO) cardiomyocytes of UNx rats led to a decreased transmural
206 re phospho-histone H3+ (a marker of mitosis) cardiomyocytes (p = 0.04), and noncardiomyocytes (p = 0.
209 ich sustained FGF signaling acts to suppress cardiomyocyte plasticity and to preserve the integrity o
210 erexpression of Tnni3k in zebrafish promoted cardiomyocyte polyploidization and compromised heart reg
211 rentiate into vascular endothelial cells and cardiomyocytes possibly by FGF and BMP signaling, respec
213 study aimed to characterize a population of cardiomyocyte precursors in the neonatal heart and to de
214 uripotent stem cells (iPSC) and iPSC-derived cardiomyocytes presents a valuable opportunity to replen
218 hat GAS2L3 deficiency leads to inhibition of cardiomyocyte proliferation and to cardiomyocyte hypertr
219 identified Cnot3 as a critical regulator in cardiomyocyte proliferation at the late stage of cardiac
220 tudy supported the model that Cnot3 enhances cardiomyocyte proliferation by promoting cell cycle inhi
224 Uncovering the molecular basis of mammalian cardiomyocyte proliferation may eventually lead to bette
225 yocardial infarction, although the degree of cardiomyocyte proliferation observed in this model sugge
228 combined with 3D confocal imaging of beating cardiomyocytes provides a functional 3D map of active EC
230 nd functional features, and drug response of cardiomyocytes (PSC-CMs) and endothelial cells (PSC-ECs)
232 uingly, transgenic overexpression of GCH1 in cardiomyocytes reduces the thickness of interventricular
236 d functional maturation of stem cell-derived cardiomyocytes remains a key challenge for applications
237 Here, we tested the hypothesis that enhanced cardiomyocyte renewal in transgenic mice expressing cycl
239 an myocardium can undergo a low level of new cardiomyocyte renewal of approximately 1% per year, whic
242 By contrast, REST overexpression in cultured cardiomyocytes represses p21 and increases proliferation
245 dingly, Ca(2+)-spark analysis in isolated TG cardiomyocytes revealed remarkably reduced Ca(2+) leakag
247 trations or pathological hypokalaemia, human cardiomyocytes show both hyperpolarized and depolarized
249 resolution and then seeded the scaffold with cardiomyocytes, smooth muscle cells, and endothelial cel
250 human-induced pluripotent stem cell-derived cardiomyocytes, smooth muscle cells, and endothelial cel
251 ng myocardial infarction, myofibroblast- and cardiomyocyte-specific activation of Smad3 has contrasti
252 ospho-silenced cTnIS200A, each driven by the cardiomyocyte-specific alpha-myosin heavy chain promoter
255 iological and stress conditions, mice with a cardiomyocyte-specific deletion of PMCA1 (PMCA1(cko) ) a
256 both organ and cellular levels in mice with cardiomyocyte-specific deletion of PMCA1 (PMCA1(cko) ) T
257 ecreases sustained cardiac function, but the cardiomyocyte-specific effects of SRC-2 in these changes
260 is a critical barrier for the acquisition of cardiomyocyte-specific splicing patterns in fibroblasts.
261 se a range of state-of-the-art methods and a cardiomyocyte-specific, tamoxifen-activated, PKP2 knocko
264 ctivity of protein clearance pathways in the cardiomyocyte, such as proteasomal degradation and autop
265 uld supply basic energy needs in non-beating cardiomyocytes, suggesting that increased collateral cir
266 rogenic Cl(-)/HCO3(-) exchange activities in cardiomyocytes, suggesting the potential role of Slc26a6
267 MEF2A and MEF2D were absolutely required for cardiomyocyte survival, whereas MEF2C, despite its major
272 ) oscillations with a decreased frequency in cardiomyocytes through recordings of intracellular Ca(2+
273 CPVT2 and to use the generated hiPSC-derived cardiomyocytes to gain insights into patient-specific di
275 yocytes increased cAMP levels and sensitized cardiomyocytes to isoprenaline-induced augmentation of c
277 induced pluripotent stem cell (iPSC) derived cardiomyocytes treated with doxorubicin, both PLCE1 and
280 regulator of cell viability and apoptosis in cardiomyocytes via simultaneous activation of p53 and ca
281 Force development in membrane-permeabilized cardiomyocytes was reduced because of decreased myofibri
282 Increased diastolic Ca(2+) release in wt-PMI cardiomyocytes was related to hyperphosphorylation of ry
283 The reduction of Ito currents in UNx EPI cardiomyocytes was secondary to downregulation of KChIP2
287 We found that TLR3- and STAT1-deficient cardiomyocytes were not more susceptible to Coxsackie vi
289 ced Ca(2+)-release events in the CPVT2-hiPSC cardiomyocytes when compared with healthy control cells.
290 th enhanced Kir2.1 expression and mouse HL-1 cardiomyocytes with ectopic expression of K2P1 channels
291 m 1 of Kir2 (Kir2.1) channels and mouse HL-1 cardiomyocytes with ectopic expression of two pore-domai
292 Suppressing the mitophagy pathway in HL-1 cardiomyocytes with either small interfering RNA (siRNA)
293 the hypothesis, we treated murine atrial HL1 cardiomyocytes with increasing doses of homocysteine or
294 tnatal myocardium, including: (1) rod-shaped cardiomyocytes with M bands assembled as a functional sy
295 Herein, we demonstrated that stimulation of cardiomyocytes with phenylephrine (PE), a well known hyp
296 iew cytosolic and nuclear Ca(2+) dynamics in cardiomyocytes with respect to their impact on Ca(2+)-de
297 itionally, pHi is elevated in Slc26a6(-/)(-) cardiomyocytes with slower recovery kinetics from intrac
298 terns are pivotal characteristics of failing cardiomyocytes, with several excitation-transcription co
299 sulted in a modest increase in c-kit-derived cardiomyocytes, with significant increases in the number
300 mental properties of ECC couplons in beating cardiomyocytes without pharmacological interventions.
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。